TLR7 and gastroesophageal junction adenocarcinoma: In 2019, Diakowska et al. revealed that both the mRNA and protein expression levels of TLR7 were significantly higher in patients with gastro‐esophageal junction adenocarcinoma than in healthy individuals.29